Cytokinetics, Inc. (CYTK)

62.41 +2.00 (+3.31%) USD  |  NASDAQ  |  Mar 09, 16:00
62.41 0.00 (0.00%) After-Hours: 16:07
More

Cytokinetics Preferred Stock Dividend (% of Annual Revenues)

Preferred Stock Dividend (% of Annual Revenues) Chart

View Preferred Stock Dividend (% of Annual Revenues) for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock Dividend (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years

View Preferred Stock Dividend (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock Dividend (% of Annual Revenues) Benchmarks

View Preferred Stock Dividend (% of Annual Revenues) Benchmarks
Start Trial
Bristol Myers Squibb Co. Upgrade
Molina Healthcare, Inc. Upgrade
Lifecore Biomedical, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade